Xanthus Pharmaceuticals
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Xanthus Pharmaceuticals - overview
Location
Cambridge, MA, US
Primary Industry
Pharmaceuticals
About
Xanthus Pharmaceuticals is a US-based bio pharmaceutical company that operates as a deveeloper of small-molecule therapeutics for the treatment of cancer and autoimmune disorders.
Current Investors
HealthCare Ventures, Oxford Bioscience Partners, CDIB Capital Group
Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.